Visfatin Serum Levels Predict Mortality in Critically Ill Patients

Figure 1

Visfatin levels in critically ill patients. (a) Visfatin serum concentrations (displayed as log visfatin) are significantly elevated in critically ill patients compared with controls. (b–e) Subgroup analyses of visfatin levels in critically ill patients, according to sepsis (b), obesity (c) (defined by body mass index (BMI) above 30 kg/m²), diabetes (d), or disease severity (APACHE II score above 10). (f) Visfatin levels correlate with APACHE II score in critically ill patients.

(a)

(b)

(c)

(d)

(e)

(f)